OKYO Pharma Ltd ADR Strategic Asset Allocation Index
OKYO Pharma Ltd ADR strategic asset allocation index. OKYO Pharma Ltd ADR (OKYO) has a Strategic Asset Allocation Index of 0.1% as of March 2022. Strategic assets (PP&E of $3.98K plus long-term investments of $-) total $3.98K, measured against net assets of $2.95 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is OKYO Pharma Ltd ADR's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of OKYO Pharma Ltd ADR (2019–2022)
Strategic asset allocation index of OKYO Pharma Ltd ADR from 2019 to 2022. This chart shows how OKYO Pharma Ltd ADR's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2022. As of March 2022, the index stands at 0.1%, representing strategic assets of $3.98K against net assets of $2.95 Million USD. Check how tangible is OKYO Pharma Ltd ADR's equity to evaluate the tangible quality of the company's equity base.
OKYO Pharma Ltd ADR Strategic Asset Allocation Index by Year (2019–2022)
OKYO Pharma Ltd ADR strategic asset allocation index by year from 2019 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for OKYO Pharma Ltd ADR from 2019 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of OKYO Pharma Ltd ADR.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $3.98K | $3.98K | $- | $2.95 Million | ▼ -1.3 pp |
| 2021 | 1.4% | $75.81K | $75.81K | $- | $5.32 Million | ▲ +1.2 pp |
| 2019 | 0.3% | $847.00 | $847.00 | $- | $333.14K | — |